My cart
In the shopping cart is not goods, to choose and buy!
  • Product Name
  • Size
  • Quantity
  • Amount
    Selected items : 0 pieces Total : CHECK OUT()
    Catalog No: V0671
    CAS No. (CAS Registry Number): 641571-10-0
    Description: Nilotinib (formerly also known as AMN-107, AMN107; trade name Tasigna) is a potent, orally bioavailable aminopyrimidine-based Bcr-Abl inhibitor with antineoplastic activity. It inhib...
    Catalog No: V0672
    CAS No. (CAS Registry Number): 839706-07-9
    Description: GNF-7 (GNF7; GNF 7) is a novel, potent, orally bioactive/bioavailable Bcr-Abl kinase inhibitor with potential anticancer activity. It inhibits the following kinases: M351T, T315I, E2...
    Catalog No: V0673
    CAS No. (CAS Registry Number): 926037-48-1
    Description: Radotinib (formerly IY-5511; IY5511; trade name Supect) is a novel, potent, selective, orally bioavailable, and 2nd generation BCR-ABL1 tyrosine kinase inhibitor with potential ...
    Catalog No: V0674
    CAS No. (CAS Registry Number): 778277-15-9
    Description: GNF-5 (GNF 5; GNF5), a GNF-2 analog with better pharmacokinetic profiles,  is a potent, selective and allosteric/non-ATP competitive Bcr-Abl inhibitor with potential antica...
    Catalog No: V0675
    CAS No. (CAS Registry Number): 1421783-64-3
    Description: Olverembatinib Dimesylate (GZD-824; HQP-1351; trade name in China: Nailike), the dimesylate salt of GZD824 (HQP1351), is a novel, potent, orally bioavailable Bcr-Abl inhibitor w...
    Catalog No: V0676
    CAS No. (CAS Registry Number): 260415-63-2
    Description: PD173955 (PD-173955), a src-selective tyrosine kinase inhibitor, is a novel and potent Bcr-Abl inhibitor with potential anticancer activity. It inhibits Bcr-Abl with an IC50 of ...
    10页次1/2首页<12>尾页
    Products are for research use only;  We do not sell to patients
    Tel: 1-708-310-1919
    Fax: 1-708-557-7486
    Subscribe to our E-newsletter
    • Name*
    • *
    • E-mail*
    • *
    • instructions:
    • *
    Copyright 2020 InvivoChem LLC | All Rights Reserved